Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mitochondria in Huntington’s disease: implications in pathogenesis and mitochondrial-targeted therapeutic strategies
Anamaria Jurcău, CarolinaMaria Jurcau
Neural Regeneration Research (2022) Vol. 18, Iss. 7, pp. 1472-1472
Open Access | Times Cited: 25

Showing 25 citing articles:

Neuroinflammation and neurodegeneration in Huntington’s disease: genetic hallmarks, role of metals and organophosphates
Omkar Kumar Kunwar, Shamsher Singh
Neurogenetics (2025) Vol. 26, Iss. 1
Closed Access | Times Cited: 2
Study insights in the role of PGC-1α in neurological diseases: mechanisms and therapeutic potential
Mibo Tang, Yixuan Liu, Zhengwei Hu, et al.
Frontiers in Aging Neuroscience (2025) Vol. 16
Open Access | Times Cited: 1
Mitochondrial Bioenergy in Neurodegenerative Disease: Huntington and Parkinson
Annalisa Tassone, Maria Meringolo, Giulia Ponterio, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7221-7221
Open Access | Times Cited: 14
Mitochondrial targeted antioxidants as potential therapy for huntington’s disease
Shubham Upadhayay, Puneet Kumar
Pharmacological Reports (2024) Vol. 76, Iss. 4, pp. 693-713
Closed Access | Times Cited: 5
The role of mitochondrial dysfunction in Huntington’s disease: Implications for therapeutic targeting
Deepak Chandra Joshi, M. Chavan, Kajal Gurow, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 183, pp. 117827-117827
Open Access
The fundamental role of mitochondria–endoplasmic reticulum contacts in ageing and declining healthspan
Richard M. Monaghan
Open Biology (2025) Vol. 15, Iss. 2
Open Access
Autophagy: a double-edged sword in ischemia–reperfusion injury
Laura H. Tang, Wangzheqi Zhang, Liao Yan, et al.
Cellular & Molecular Biology Letters (2025) Vol. 30, Iss. 1
Open Access
Advances in research on mitochondrial dysfunction in neurodegenerative diseases
Yao Zhang, Xiaowen Li, Yuan Zhang, et al.
Journal of Neurology (2025) Vol. 272, Iss. 5
Closed Access
Transmission-selective muscle pathology induced by the active propagation of mutant huntingtin across the human neuromuscular synapse
Margarita C. Dinamarca, Laura Colombo, Urszula Brykczynska, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 16
Open Access | Times Cited: 3
Emerging antibody-based therapies for Huntington’s disease: current status and perspectives for future development
Anamaria Jurcău, Aurel Simion, Maria Carolina Jurcău
Expert Review of Neurotherapeutics (2024) Vol. 24, Iss. 3, pp. 299-312
Closed Access | Times Cited: 3
Mitochondrial Dysfunction in Repeat Expansion Diseases
Alberto Giménez-Bejarano, Eva Alegre-Cortés, Sokhna M. S. Yakhine-Diop, et al.
Antioxidants (2023) Vol. 12, Iss. 8, pp. 1593-1593
Open Access | Times Cited: 6
Interactions of amyloidogenic proteins with mitochondrial protein import machinery in aging-related neurodegenerative diseases
Ashley L. Reed, Wayne Mitchell, Andrei T. Alexandrescu, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 6
Mitochondrial Bioenergy in Neural Disease: Huntington and Parkinson
Annalisa Tassone, Maria Meringolo, Giulia Ponterio, et al.
(2023)
Open Access | Times Cited: 5
Mutant-Huntingtin Molecular Pathways Elucidate New Targets for Drug Repurposing
V.S. Makeeva, Nadezhda S. Dyrkheeva, Olga I. Lavrik, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16798-16798
Open Access | Times Cited: 5
Neurochemical changes in the progression of Huntington's disease: A meta-analysis of in vivo 1H-MRS studies
Yinghua Jing, Imis Dogan, Kathrin Reetz, et al.
Neurobiology of Disease (2024) Vol. 199, pp. 106574-106574
Open Access | Times Cited: 1
Unraveling mitochondrial dysfunction: comprehensive perspectives on its impact on neurodegenerative diseases
Abdul Aziz Mohamed Yusoff, Siti Zulaikha Nashwa Mohd Khair
Reviews in the Neurosciences (2024)
Open Access | Times Cited: 1
Mitochondrial DNA editing: Key to the treatment of neurodegenerative diseases
Ye Hong, Ying Song, Wenjun Wang, et al.
Genes & Diseases (2024) Vol. 12, Iss. 4, pp. 101437-101437
Open Access | Times Cited: 1
Etiology and treatment challenges for neurodegenerative disorders
Nitu L. Wankhede, Mayur B. Kale, Prajwali V Shende, et al.
Elsevier eBooks (2024), pp. 1-25
Closed Access | Times Cited: 1
F2,6BP restores mitochondrial genome integrity in Huntingtons Disease
Anirban Chakraborty, Santi M. Mandal, Mikita Mankevich, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
SUMO modification in Huntington's disease: Unraveling complex mechanisms for therapeutic insights
Charlene Smith, Joan S. Steffan, Leslie M. Thompson
Elsevier eBooks (2024), pp. 259-283
Closed Access
Molecular Mechanisms in the Design of Novel Targeted Therapies for Neurodegenerative Diseases
Ilona Nowak, M. Pazdzior, Robert Sarna, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 6, pp. 5436-5453
Open Access
An insight into allele-selective approaches to lowering mutant huntingtin protein for Huntington’s disease treatment
Jun Yao, Ting Liu, Xin-Ru Hu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117557-117557
Closed Access
Docosahexaenoic Acid (DHA) Supplementation in a Triglyceride Form Prevents from Polyglutamine-Induced Dysfunctions in Caenorhabditis elegans
Ignasi Mora, Àngel Teixidó, Rafael P. Vázquez‐Manrique, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12594-12594
Open Access
A narrative review of phase III and IV clinical trials for the pharmacological treatment of Huntington’s disease in adults
Mohammed Alharthi
Medicine (2024) Vol. 103, Iss. 52, pp. e41073-e41073
Open Access
VDAC1: A Key Player in the Mitochondrial Landscape of Neurodegeneration
Shirel Argueti-Ostrovsky, Shir Barel, Joy Kahn, et al.
Biomolecules (2024) Vol. 15, Iss. 1, pp. 33-33
Open Access
Page 1

Scroll to top